Hope or hype : the obsession with medical advances and the high cost of false promises / / Richard A. Deyo, Donald L. Patrick.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Year of Publication: | 2005 |
Language: | English |
Online Access: | |
Physical Description: | xvi, 335 p. :; ill. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
5003001805 |
---|---|
ctrlnum |
(MiAaPQ)5003001805 (Au-PeEL)EBL3001805 (CaPaEBR)ebr10075614 (CaONFJC)MIL112625 (OCoLC)748521033 |
collection |
bib_alma |
record_format |
marc |
spelling |
Deyo, Richard A. Hope or hype [electronic resource] : the obsession with medical advances and the high cost of false promises / Richard A. Deyo, Donald L. Patrick. New York : AMACOM, American Management Association, c2005. xvi, 335 p. : ill. Includes bibliographical references (p. [291]-326) and index. Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Medical innovations United States Evaluation. Medical technology United States Evaluation. Medical care Technological innovations United States Evaluation. Medical care United States Evaluation. Medical innovations Economic aspects United States. Medical technology United States Cost effectiveness. Medical care Technological innovations United States Cost effectiveness. Medical care, Cost of United States. Electronic books. Patrick, Donald L. ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3001805 Click to View |
language |
English |
format |
Electronic eBook |
author |
Deyo, Richard A. |
spellingShingle |
Deyo, Richard A. Hope or hype the obsession with medical advances and the high cost of false promises / Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. |
author_facet |
Deyo, Richard A. Patrick, Donald L. ProQuest (Firm) ProQuest (Firm) |
author_variant |
r a d ra rad |
author2 |
Patrick, Donald L. ProQuest (Firm) |
author2_variant |
d l p dl dlp |
author2_role |
TeilnehmendeR TeilnehmendeR |
author_corporate |
ProQuest (Firm) |
author_sort |
Deyo, Richard A. |
title |
Hope or hype the obsession with medical advances and the high cost of false promises / |
title_sub |
the obsession with medical advances and the high cost of false promises / |
title_full |
Hope or hype [electronic resource] : the obsession with medical advances and the high cost of false promises / Richard A. Deyo, Donald L. Patrick. |
title_fullStr |
Hope or hype [electronic resource] : the obsession with medical advances and the high cost of false promises / Richard A. Deyo, Donald L. Patrick. |
title_full_unstemmed |
Hope or hype [electronic resource] : the obsession with medical advances and the high cost of false promises / Richard A. Deyo, Donald L. Patrick. |
title_auth |
Hope or hype the obsession with medical advances and the high cost of false promises / |
title_new |
Hope or hype |
title_sort |
hope or hype the obsession with medical advances and the high cost of false promises / |
publisher |
AMACOM, American Management Association, |
publishDate |
2005 |
physical |
xvi, 335 p. : ill. |
contents |
Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. |
callnumber-first |
R - Medicine |
callnumber-subject |
RA - Public Medicine |
callnumber-label |
RA418 |
callnumber-sort |
RA 3418.5 M4 D49 42005 |
genre |
Electronic books. |
genre_facet |
Electronic books. |
geographic_facet |
United States United States. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3001805 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
610 - Medicine & health |
dewey-full |
610/.28 |
dewey-sort |
3610 228 |
dewey-raw |
610/.28 |
dewey-search |
610/.28 |
oclc_num |
748521033 |
work_keys_str_mv |
AT deyoricharda hopeorhypetheobsessionwithmedicaladvancesandthehighcostoffalsepromises AT patrickdonaldl hopeorhypetheobsessionwithmedicaladvancesandthehighcostoffalsepromises AT proquestfirm hopeorhypetheobsessionwithmedicaladvancesandthehighcostoffalsepromises |
status_str |
n |
ids_txt_mv |
(MiAaPQ)5003001805 (Au-PeEL)EBL3001805 (CaPaEBR)ebr10075614 (CaONFJC)MIL112625 (OCoLC)748521033 |
is_hierarchy_title |
Hope or hype the obsession with medical advances and the high cost of false promises / |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1792330828370411520 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05131nam a22004574a 4500</leader><controlfield tag="001">5003001805</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">040922s2005 nyua sb 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2004022295</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0814408451</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5003001805</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL3001805</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10075614</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL112625</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)748521033</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA418.5.M4</subfield><subfield code="b">D49 2005</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610/.28</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Deyo, Richard A.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hope or hype</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">the obsession with medical advances and the high cost of false promises /</subfield><subfield code="c">Richard A. Deyo, Donald L. Patrick.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">New York :</subfield><subfield code="b">AMACOM, American Management Association,</subfield><subfield code="c">c2005.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xvi, 335 p. :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. [291]-326) and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical innovations</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical technology</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical care</subfield><subfield code="x">Technological innovations</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical care</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical innovations</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical technology</subfield><subfield code="z">United States</subfield><subfield code="x">Cost effectiveness.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical care</subfield><subfield code="x">Technological innovations</subfield><subfield code="z">United States</subfield><subfield code="x">Cost effectiveness.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical care, Cost of</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patrick, Donald L.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3001805</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |